Christopher J. Child

1.3k total citations
43 papers, 873 citations indexed

About

Christopher J. Child is a scholar working on Endocrinology, Diabetes and Metabolism, Genetics and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Christopher J. Child has authored 43 papers receiving a total of 873 indexed citations (citations by other indexed papers that have themselves been cited), including 36 papers in Endocrinology, Diabetes and Metabolism, 13 papers in Genetics and 10 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Christopher J. Child's work include Growth Hormone and Insulin-like Growth Factors (21 papers), Diabetes Management and Research (15 papers) and Diabetes Treatment and Management (9 papers). Christopher J. Child is often cited by papers focused on Growth Hormone and Insulin-like Growth Factors (21 papers), Diabetes Management and Research (15 papers) and Diabetes Treatment and Management (9 papers). Christopher J. Child collaborates with scholars based in United States, United Kingdom and Germany. Christopher J. Child's co-authors include Werner Blum, Alan G. Zimmermann, Charmian A. Quigley, Gordon B. Cutler, Cheri Deal, Elena P. Shavrikova, Leslie L. Robison, Whitney W. Woodmansee, Eva Marie Erfurth and Andrea Attanasio and has published in prestigious journals such as New England Journal of Medicine, The Journal of Clinical Endocrinology & Metabolism and Biochemistry.

In The Last Decade

Christopher J. Child

41 papers receiving 858 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Christopher J. Child United States	18	688	282	273	224	123	43	873
Elena P. Shavrikova Germany	10	549 0.8×	295 1.0×	203 0.7×	234 1.0×	116 0.9×	14	732
Roland Pfaeffle Germany	14	493 0.7×	242 0.9×	67 0.2×	219 1.0×	61 0.5×	30	650
Andrea Secco Italy	10	383 0.6×	142 0.5×	76 0.3×	122 0.5×	47 0.4×	20	493
RG Rosenfeld United States	17	598 0.9×	212 0.8×	104 0.4×	324 1.4×	145 1.2×	30	746
C. P. Schwarze Germany	15	325 0.5×	249 0.9×	173 0.6×	234 1.0×	111 0.9×	26	671
MB Ranke Germany	11	308 0.4×	167 0.6×	165 0.6×	217 1.0×	78 0.6×	14	541
C Y Hayashida Brazil	12	476 0.7×	295 1.0×	58 0.2×	309 1.4×	45 0.4×	18	873
A. Silbergeld Israel	16	646 0.9×	229 0.8×	86 0.3×	275 1.2×	112 0.9×	45	763
Manuel Fontoura Portugal	13	322 0.5×	99 0.4×	120 0.4×	164 0.7×	32 0.3×	44	556
Rikke Hjortebjerg Denmark	16	347 0.5×	97 0.3×	67 0.2×	225 1.0×	117 1.0×	37	610

Countries citing papers authored by Christopher J. Child

Since Specialization

Citations

This map shows the geographic impact of Christopher J. Child's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christopher J. Child with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christopher J. Child more than expected).

Fields of papers citing papers by Christopher J. Child

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Christopher J. Child. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christopher J. Child. The network helps show where Christopher J. Child may publish in the future.

Co-authorship network of co-authors of Christopher J. Child

This figure shows the co-authorship network connecting the top 25 collaborators of Christopher J. Child. A scholar is included among the top collaborators of Christopher J. Child based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Christopher J. Child. Christopher J. Child is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Carlton, Jill, Philip A. Powell, Melanie Broadley, et al.. (2024). Development of a new health-related quality of life measure for people with diabetes who experience hypoglycaemia: the Hypo-RESOLVE QoL. Diabetologia. 67(8). 1536–1551. 2 indexed citations

Cambron‐Mellott, M. Janelle, Jiat Ling Poon, Qianqian Wang, et al.. (2022). Development of a Measure to Assess Attitudes Towards Nasal versus Autoinjector Glucagon Delivery Devices for Treatment of Severe Hypoglycemia. Diabetes Metabolic Syndrome and Obesity. Volume 15. 3601–3615.

Carlton, Jill, Philip A. Powell, Donna Rowen, et al.. (2022). Producing a preference‐based quality of LIFE measure to quantify the impact of HYPOGLYCAEMIA on people living with diabetes: A mixed‐methods research protocol. Diabetic Medicine. 40(3). e15007–e15007. 4 indexed citations

Hinnen, Deborah, et al.. (2022). Nasal Glucagon Is Easier to Use and More Preferred and Needs Less Effort to Administer Than Injectable Glucagon: User Perceptions of Glucagon Administration During Severe Hypoglycemia Simulation. Endocrine Practice. 28(5). 486–493. 4 indexed citations

Bajpai, Shailendra, M. Janelle Cambron‐Mellott, Eugenia Y. Peck, et al.. (2019). PDB94 FACTORS INFLUENCING PREFERENCES FOR GLUCAGON DELIVERY DEVICES AMONG PATIENTS WITH DIABETES, CAREGIVERS, AND ACQUAINTANCES. Value in Health. 22. S156–S156. 1 indexed citations

Deal, Cheri, Susan Kirsch, Jean‐Pierre Chanoine, et al.. (2018). Growth hormone treatment of Canadian children: results from the GeNeSIS phase IV prospective observational study. CMAJ Open. 6(3). E372–E383. 11 indexed citations

Pfäffle, Roland, Christof Land, Eckhard Schönaü, et al.. (2018). Growth Hormone Treatment for Short Stature in the USA, Germany and France: 15 Years of Surveillance in the Genetics and Neuroendocrinology of Short-Stature International Study (GeNeSIS). Hormone Research in Paediatrics. 90(3). 169–180. 23 indexed citations

Blum, Werner, Jürgen Klammt, Serge Amselem, et al.. (2018). Screening a large pediatric cohort with GH deficiency for mutations in genes regulating pituitary development and GH secretion: Frequencies, phenotypes and growth outcomes. EBioMedicine. 36. 390–400. 22 indexed citations

Yokoya, Susumu, Tomonobu Hasegawa, Keiichi Ozono, et al.. (2017). Incidence of diabetes mellitus and neoplasia in Japanese short-statured children treated with growth hormone in the Genetics and Neuroendocrinology of Short Stature International Study (GeNeSIS). Clinical Pediatric Endocrinology. 26(4). 229–241. 2 indexed citations

10.

Benabbad, Imane, Myriam Rosilio, Christopher J. Child, et al.. (2016). Safety Outcomes and Near-Adult Height Gain of Growth Hormone-Treated Children with SHOX Deficiency: Data from an Observational Study and a Clinical Trial. Hormone Research in Paediatrics. 87(1). 42–50. 26 indexed citations

11.

Child, Christopher J., Werner Blum, Cheri Deal, et al.. (2016). Development of additional pituitary hormone deficiencies in pediatric patients originally diagnosed with isolated growth hormone deficiency due to organic causes. European Journal of Endocrinology. 174(5). 669–679. 12 indexed citations

12.

Child, Christopher J., Alan G. Zimmermann, Nan Jia, et al.. (2016). Assessment of Primary Cancer Incidence in Growth Hormone-Treated Children: Comparison of a Multinational Prospective Observational Study with Population Databases. Hormone Research in Paediatrics. 85(3). 198–206. 12 indexed citations

13.

Child, Christopher J., G. Kalifa, Christine Jones, et al.. (2015). Radiological Features in Patients with Short Stature Homeobox-Containing (SHOX) Gene Deficiency and Turner Syndrome before and after 2 Years of GH Treatment. Hormone Research in Paediatrics. 84(1). 14–25. 17 indexed citations

14.

Child, Christopher J., et al.. (2015). Incidence of primary cancers and intracranial tumour recurrences in GH-treated and untreated adult hypopituitary patients: analyses from the Hypopituitary Control and Complications Study. European Journal of Endocrinology. 172(6). 779–790. 45 indexed citations

15.

Mo, Daojun, Maria Fleseriu, Rong Qi, et al.. (2015). Fracture risk in adult patients treated with growth hormone replacement therapy for growth hormone deficiency: a prospective observational cohort study. The Lancet Diabetes & Endocrinology. 3(5). 331–338. 41 indexed citations

16.

Blum, Werner, Judith L. Ross, Alan G. Zimmermann, et al.. (2013). GH Treatment to Final Height Produces Similar Height Gains in Patients With SHOX Deficiency and Turner Syndrome: Results of a Multicenter Trial. The Journal of Clinical Endocrinology & Metabolism. 98(8). E1383–E1392. 66 indexed citations

17.

Woodmansee, Whitney W., Alan G. Zimmermann, Christopher J. Child, et al.. (2013). Incidence of second neoplasm in childhood cancer survivors treated with GH: an analysis of GeNeSIS and HypoCCS. European Journal of Endocrinology. 168(4). 565–573. 47 indexed citations

18.

Blum, Werner, Cheri Deal, Alan G. Zimmermann, et al.. (2013). Development of additional pituitary hormone deficiencies in pediatric patients originally diagnosed with idiopathic isolated GH deficiency. European Journal of Endocrinology. 170(1). 13–21. 32 indexed citations

19.

Child, Christopher J., et al.. (2011). Prevalence and Incidence of Diabetes Mellitus in GH-Treated Children and Adolescents: Analysis from the GeNeSIS Observational Research Program. The Journal of Clinical Endocrinology & Metabolism. 96(6). E1025–E1034. 59 indexed citations

20.

Attanasio, Andrea, Elena P. Shavrikova, Werner Blum, et al.. (2004). Continued Growth Hormone (GH) Treatment after Final Height Is Necessary to Complete Somatic Development in Childhood-Onset GH-Deficient Patients. The Journal of Clinical Endocrinology & Metabolism. 89(10). 4857–4862. 73 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact